The 3 R’s of Medical Device Development: Research, Regulation, Reimbursement

2016
Navigation

In our last blog, we laid out five pre-funding essentials for early-stage startups. Today, we want to delve deeper into three critical pillars of the medical device development cycle: Research, Regulation, and Reimbursement.

Each of these elements carries massive weight—not just at the pre-funding stage, but throughout your entire journey to commercialization.

1. Research: Looking Beyond the Technology

Good technical research is the foundation of any innovative medical device, but lab success isn’t enough. To attract investors, you must thoroughly understand the commercial landscape.

Even if your initial market analysis looks promising, you need to dig deeper into these critical facets:

  • Market Awareness: Does your target market already know they need your device, or will your launch require extensive provider and patient education?
  • Acquisition Strategy: If your ultimate goal is an exit, how will you quickly infiltrate existing market channels to prove your device’s commercial viability?
  • Investor Appeal: Effectively demonstrating a clear path to market dominance is what makes your medical device startup funding proposal stand out to angel investors and VCs.

2. Regulation: Building a Proactive Pathway

Plain and simple: your device must gain regulatory approval in your target countries, or your business stalls. No one will fund, sustain, or acquire a device bogged down by regulatory hurdles.

A successful regulatory approval strategy starts early and requires precise execution:

  • Device Classification: In the U.S., Class I, II, and III devices face increasingly stringent controls. Classification depends heavily on both your intended use and specific indications for use.
  • Strategic Analysis: Determining your path means evaluating potential exemptions, predicates, and clinical data requirements.
  • Risk Mitigation: Mapping this out early keeps your timeline on track and gives investors the confidence that your compliance pathway is secure.

3. Reimbursement: Overcoming the Commercial Achilles’ Heel

You’ve done the market research and mapped out your regulatory strategy. Now comes the factor that catches many early-stage companies off guard: medical device reimbursement. You can have the most revolutionary device in the world, but if insurance providers won’t pay for it, adoption will stall.

To protect your company’s valuation and long-term funding prospects, you must address these questions early:

  • Will your device fall into an existing, standard reimbursement class?
  • Will it require a completely new reimbursement code?
  • If a new code is needed, how will you build the robust clinical and financial case required to convince payers?

An initial reimbursement analysis is non-negotiable to understand exactly where your device stands before burning through capital.

Accelerate Your Medical Device Launch

At REV.1 Engineering, our program management protocol takes every aspect of your growing business into account. Thanks to our long-standing relationships with industry specialists, we can instantly bridge the talent gaps on your team, providing access to:

  • Medical device reimbursement analysts
  • Regulatory approval consultants
  • Expert market researchers

If you are an early-stage startup looking for the angel investment needed to scale, we are ready to dive in. We will prepare a comprehensive gap analysis to highlight exactly what you need to secure funding—and we’ll get your device moving 2x faster than building an in-house team from scratch.

Get Your Start-Up Started

Let’s discuss your project. Connect with us today:

— Eric & Phil